Ken Shultis is Managing Partner, Rondaxe Pharma, a CMC (chemistry, manufacturing and controls) consulting firm providing multiple services, including product development planning, quality systems design, cost of goods sold evaluations of active pharmaceutical ingredients and formulations for small molecules and biologicals, technology transfer support, process and facility engineering, analytical methods, and supplier negotiations. He joined Rondaxe in 2008. He previously was Vice President of Operations and General Manager of Organichem for AMRI (now Curia) after founding American Advanced Organics, where he served as President for two years. Prior to that, he spent 14 years at Bristol-Myers Squibb as Director of Pilot Plant Development,  where he led several multiple site plant introduction programs. He also worked in process R&D at Merck & Co. and in fermentation development at Abbott Laboratories (now AbbVie). He earned his BSc. in chemical engineering from the University of Wisconsin and his M.Sc. in chemical engineering from the University of Minnesota. 

Sessions

Best Practices Platform: Industry Case Studies